Monday, July 4, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Characteristics of vaccine hesitancy in England at the community level

by Medical Finance
in Coronavirus
Study: Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study. annaevlanova / Shutterstock
9
SHARES
101
VIEWS
Share on FacebookShare on Twitter

In a recent study posted to the medRxiv* preprint server, researchers evaluated the characteristics of coronavirus disease 2019 (COVID-19) vaccine uptake in England at a community level.

Study: Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study. annaevlanova / ShutterstockStudy: Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study. annaevlanova / Shutterstock

The COVID-19 vaccination campaign has been implemented globally to immunize populations against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In England, the National Health Service (NHS) commenced mass vaccinations in December 2020, and over 43 million individuals had been vaccinated with at least one vaccine dose by the end of 2021. Despite the high vaccination rate, vaccine uptake varies among populations, and vaccine inequality remains a public health concern.

According to one study, income disparity was the principal cause of vaccine inequity between high- and middle-income countries. Other research groups have reported that less-educated people from ethnic minorities with low annual income and low awareness of COVID-19-related health risks had higher distrust towards immunization. Consistent with other reports, South Asians and Black people in the United Kingdom (UK) were less likely to vaccinate than the White population.

The study

The current cross-sectional study assessed vaccine uptake in people aged 12 years or above in England. As of January 1, 2022, the authors retrieved cumulative vaccination data corresponding to the middle layer super output areas (MSOA). Vaccine uptake determinants were evaluated at a high geographical resolution by considering covariates associated with COVID-19 mortality in 2020, political views, socio-demographic characteristics, chronic physical and mental health conditions, and vaccine accessibility.

Socio-demographics were profiled by computing the percentage of Black and minority ethnic (BME), index of multiple deprivations (IMD), percentage of people aged 12 – 24 years, and >65 years in each MSOA. Each MSOA was categorized as predominantly urban (PU) or rural (PR) or urban with significant rural (UR). Political opinion was characterized by computing the percentage of those who voted in favor of the 2016 Brexit referendum and the 2019 general election results. A Bayesian hierarchical model was used to assess the relationship of uptake of COVID-19 vaccines and the community-level characteristics.

Posterior mean of vaccine uptake up until 01-01-2022 in each Middle Layer Super Output Area in England (left) and for the most populated cities accounting for a total 11 212 813 population [47] (right).

Posterior mean of vaccine uptake up until 01-01-2022 in each Middle Layer Super Output Area in England (left) and for the most populated cities accounting for a total 11 212 813 population [47] (right).

Results

The national posterior mean of COVID-19 vaccine uptake was estimated at 81.1%, ranging from 37.6 % in Leeds city to 93.9% in Northumberland with lower uptake in city centers. The least compliant regions shared some characteristics – more likely to be deprived and situated in urban places, a high proportion of young residents and non-White ethnic groups, voting for the Labor party, and less likely to experience chronic health conditions. Contrastingly, high vaccine coverage regions were characterized by the older population, increased prevalence of chronic health conditions, and politically favoring the Conservative party.

IMD was the covariate strongly associated with low vaccine uptake. For example, people living in the most deprived places were 0.55 times less likely to be vaccinated than those living in the least disadvantaged regions. In the same line, areas with diverse and high BME populations had 38% lower odds of vaccine uptake than least ethnically-diverse places. Moreover, regions with high proportions of 12 – 24-year-olds had lower odds of vaccine uptake; areas that voted for the Conservative party had high vaccine coverage.

There was insufficient evidence for a link between the proportion of people voting for the Labor party and the Brexit referendum. Areas with a high COVID-19 mortality rate in the pre-vaccination period had higher odds of vaccine uptake; similar was the case in areas with a high prevalence of high blood pressure or asthma, and the vaccine uptake improved with the increase in vaccine accessibility.

Conclusions

The study investigated a range of characteristics at the community level and their role in vaccine uptake. The findings suggested that MSOAs with low uptake of vaccines were the most deprived and ethnically diverse with a high percentage of young people. Vaccine uptake was high across areas with awareness of COVID-19-related health risks and increased accessibility to vaccination centers.

Moreover, areas that voted for the Conservatives had higher vaccine uptake. The national and international COVID-19 policies have changed throughout 2021, increasing public awareness that might have influenced general behavior towards vaccination. A notable limiting factor was the consideration of BME proportions based on the 2011 census assuming that ethnic composition was essentially the same throughout the decade in the MSOAs.

In conclusion, the study reported that despite high national vaccine coverage in a year, multiple inequalities, mainly associated with deprivation and ethnicity, were still persistent. The authors suggested that these sections be engaged through suitable means (scientists and role models from the target communities) to lower vaccine skepticism.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Dynamics of SAR-CoV2 Viral Load Decline and Antibody Responses in COVID-19 Patients. Image Credit: Lightspring/Shutterstock

Study explores the decline in viral load and immune response in COVID-19 patients

by Medical Finance
July 4, 2022
0

A recent study posted to the Research Square* preprint server and currently under consideration at Archives of Virology described the...

Study: Edible formulations of chicken egg derived IgY antibodies neutralize SarsCoV2 Omicron RBD binding to human ACE2. Image Credit: Festa/Shutterstock.com

Edible egg-derived IgY antibodies against SARS-CoV-2 Omicron

by Medical Finance
July 4, 2022
0

Feb 23 2022 The recent emergence of a new SARS-CoV-2 variant known as Omicron has triggered another wave of COVID-19...

Study: Relating SARS-CoV-2 Variants Using Cellular Automata Imaging. Image Credit: Mediantone/Shutterstock

Cellular automata imaging-based classification of SARS-CoV-2 variants

by Medical Finance
July 4, 2022
0

In a pre-print study posted to Research Square* and currently under review at Scientific Reports, researchers classified and grouped severe acute...

Study: SARS-CoV-2 Delta Variant (AY.3) in the Feces of a Domestic Cat. Image Credit: Astrid Gast / Shutterstock

First reported case of a cat infected with SARS-CoV-2 Delta AY.3 variant

by Medical Finance
July 4, 2022
0

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is hurting our loved ones — even those that walk on four legs....

Study: Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients. Image Credit: Lightspring/Shutterstock

Immune responses in patients with varying degrees of SARS-CoV-2 infection

by Medical Finance
July 4, 2022
0

The novel severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) primarily triggers an immune condition that affects multiple organ systems. The...

Study: Understanding the immunological landscape of England during SARS-CoV2 Omicron variant wave. Image Credit: Adao/Shutterstock

Immunological landscape of England during Omicron-driven SARS-CoV-2 wave

by Medical Finance
July 4, 2022
0

In a recent study posted to the medRxiv* preprint server, researchers determined the immunological landscape of England throughout the severe acute...

Next Post
Study: Hospital length of stay in a mixed Omicron and Delta epidemic in New South Wales, Australia. Image Credit: Mai.Chayakorn/Shutterstock

Length of stay distributions of hospitalized COVID-19 cases during a mixed Omicron-Delta epidemic in Australia

Researchers analyze the role of self-deception in everyday life

Immunocompromised patients worry vaccine exemptions put them in peril

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Chimeric mRNA based COVID-19 vaccine elicits potent neutralizing antibodies and protection against Omicron and Delta. Image Credit: Kateryna Kon/Shutterstock
    Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants
  • Protein 620x480
    Experimental tool can precisely pick out interactions between immune cell and target antigen
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply